Related Experiment Video
Updated: Apr 5, 2026

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
Published on: August 28, 2015
Pharmaceutical Role Expansion and Developments in Pharmacist-Physician Communication
Alicia A Bergman1, Heather A Jaynes2, Jasmine D Gonzalvo2
1a Richard L. Roudebush VA Medical Center.
Clinical pharmacists in patient-centered medical homes face communication challenges with primary care physicians, especially regarding electronic requests and navigating new roles. Onsite collaboration improves relationships and patient safety.
Area of Science:
- Health Services Research
- Interprofessional Education
- Primary Care Medicine
Background:
- Expanded clinical pharmacist roles in patient-centered medical homes (PCMH) necessitate collaboration with primary care physicians (PCPs).
- PCPs often lack prior experience working directly with pharmacists in integrated care models.
- New pharmacist responsibilities, such as formulary control, add complexity to the interprofessional relationship.
Purpose of the Study:
- To characterize the nature of interprofessional collaboration between clinical pharmacists and PCPs.
- To explore the dynamics of communication, role navigation, and relationship building in PCMH settings.
- To identify factors influencing effective collaboration and potential barriers.
Main Methods:
- Qualitative study employing in-depth, semistructured interviews.
- Conducted with 25 clinical pharmacists and 17 PCPs across seven federally funded hospitals and clinics.
- Thematic analysis of interview data to identify key themes.
Main Results:
- Electronic communication, particularly nonformulary requests, created interprofessional tensions.
- Pharmacists used indirect communication to manage hierarchical dynamics and PCP defensiveness.
- Onsite colocation was preferred for enhancing communication and professional relationships.
Conclusions:
- Effective communication strategies are crucial for patient safety, especially concerning medication use.
- Fostering an environment where all team members can voice concerns is vital for error reduction.
- Addressing institutional communication gaps regarding formulary management and electronic request processes is necessary.
More Related Videos
09:30Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
07:23Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications
Published on: October 20, 2023
Related Concept Videos
Biopharmaceutics and Pharmacokinetics: Overview
Interdisciplinary Care: The Health Care Team-II
Physical Therapist
A physical therapist (PT) aims to restore function or prevent additional impairment in a patient following an injury or disease. Massage, heat, cold, water, sonar waves, exercises, and electrical stimulation are some treatments used by PTs to treat...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Interdisciplinary Care: The Health Care Team-I
Physicians
The physician's primary responsibility is to diagnose illness and direct the medical or surgical treatment of the condition. The authority to admit patients to a healthcare agency or institution and practice care within that setting is granted to physicians by the healthcare agency or institution...
Pharmaceutical Poisoning: Potential Scenarios
Biopharmaceutical Factors Influencing Drug Product Design: Overview